Total Debt
$116.3M
Net Debt
-$1.62B
Vaxcyte, Inc. currently has $116.3M in total debt. Net debt is -$1.62B after cash offsets. This 'Net Cash' position indicates exceptional financial strength.
Financial Fundamentals
PCVX • Quarterly Data • 5Y View
| Date | Total Debt ($B) | Cash & Inv. ($B) | Net Debt ($B) | Total Assets | Debt/Assets |
|---|---|---|---|---|---|
| 2026-03-31 | 0.12 | 1.74 | -1.62Net Cash | 3.35 | 3.5% |
| 2025-12-31 | 0.23 | 1.56 | -1.33Net Cash | 3.05 | 7.5% |
| 2025-09-30 | 0.08 | 1.71 | -1.63Net Cash | 3.17 | 2.7% |
| 2025-06-30 | 0.09 | 1.66 | -1.58Net Cash | 3.31 | 2.6% |
| 2025-03-31 | 0.09 | 1.67 | -1.58Net Cash | 3.38 | 2.6% |
| 2024-12-31 | 0.07 | 1.75 | -1.68Net Cash | 3.51 | 2.0% |
| 2024-09-30 | 0.03 | 2.18 | -2.15Net Cash | 3.56 | 0.8% |
| 2024-06-30 | 0.03 | 1.45 | -1.43Net Cash | 2.09 | 1.2% |
| 2024-03-31 | 0.03 | 1.49 | -1.46Net Cash | 2.09 | 1.3% |
| 2023-12-31 | 0.03 | 1.08 | -1.05Net Cash | 1.41 | 2.1% |
| 2023-09-30 | 0.01 | 1.27 | -1.25Net Cash | 1.50 | 0.9% |
| 2023-06-30 | 0.02 | 1.29 | -1.27Net Cash | 1.50 | 1.0% |
| 2023-03-31 | 0.02 | 0.82 | -0.81Net Cash | 1.01 | 1.6% |
| 2022-12-31 | 0.02 | 0.93 | -0.91Net Cash | 1.01 | 1.8% |
| 2022-09-30 | 0.02 | 0.36 | -0.34Net Cash | 0.41 | 4.8% |
| 2022-06-30 | 0.02 | 0.35 | -0.33Net Cash | 0.41 | 5.2% |
| 2022-03-31 | 0.02 | 0.33 | -0.31Net Cash | 0.40 | 5.6% |
| 2021-12-31 | 0.02 | 0.25 | -0.23Net Cash | 0.32 | 5.2% |
| 2021-09-30 | 0.00 | 0.28 | -0.28Net Cash | 0.35 | 0.3% |
| 2021-06-30 | 0.00 | 0.29 | -0.29Net Cash | 0.36 | 0.3% |
| 2021-03-31 | 0.00 | 0.32 | -0.32Net Cash | 0.38 | 0.3% |
| 2020-12-31 | 0.00 | 0.39 | -0.39Net Cash | 0.39 | 0.0% |
| 2020-09-30 | 0.00 | 0.40 | -0.40Net Cash | 0.40 | 0.0% |
| 2020-06-30 | 0.00 | 0.41 | -0.41Net Cash | 0.42 | 0.0% |
| 2020-03-31 | 0.00 | 0.15 | -0.15Net Cash | 0.16 | 0.0% |
| 2019-12-31 | 0.00 | 0.06 | -0.06Net Cash | 0.07 | 0.2% |
| 2019-03-31 | 0.00 | 0.07 | -0.07Net Cash | 0.00 | — |